NextGen-O2k Exploitation: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
Laner Verena (talk | contribs) No edit summary |
||
Line 14: | Line 14: | ||
== Abstract == | == Abstract == | ||
:::: | :::: Preparation for a successful market launch of the NextGen-O2k. | ||
Revision as of 11:21, 2 August 2019
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Preparation for a successful market launch of the NextGen-O2k.